SHIRE PHARMACEUTICALS LLC for SHIRE PHARMACEUTICALS LLC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 22, 2013 | $250,000 | Replaced |
| 2nd Quarter - Amendment | Oct 2, 2013 | $140,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Medicare/Medicaid spending and reform, budget issues, diabetes funding, track and trace, VA access/reimbursement/contracting, ASP and reimbursement, Regenerative Medicine, drug shortages, IPAB, Indian Health coverage and SDPI, wound care, priority list of needs for pediatric therapeutics, skin substitute technology assessments, patient registries, corporate taxes, OPPS and MPFS issues, orphan drugs, health care reform, exchanges, accountable care
| Lobbyist | Covered position, as disclosed |
|---|---|
| THERESA DIXON New | — |
| JULIE LETWAT New | — |
Pharmacy PHA
orphan drug tax credt; issues surrounding ADHD; ESRD PPS; mental health awareness, identification and treatment;binge eating disorder; drug shortages; DEA quotas; FDA funding; Trial and Experimental Studies Transparency Act; pharmaceutical and biotech related legislation; health care reform/FDASIA implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BUCKLEY | — |
| MARK LENKER New | Senior Legis. Asst., Rep.Curt Weldon |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.